Your Agenda for 2026 - Five Successful Initiatives for Pharma Supply Chain Leaders

January 2026: With 2026 just started your challenge is to prioritize and implement strategic and tactical initiatives to become even more customer centric, growing, resilient and profitable.

BCI Global recently hosted a fast and furious webinar to support Pharma Supply Chain Leaders in prioritizing their agenda for 2026. The following 5 must do’s specifically for the pharma industry have been addressed with clear roadmaps and results of peer initiatives, real life cases and frameworks ready for immediately use:

• Footprint optimization: ways to improve your company’s resilience | focus of a winning business strategy
• End-to-end visibility: how can control towers help you to improve end-to-end visibility which is so needed from a cost, quality, compliance and resilience perspective?
• Digital transformation: focus on 3 areas : supply planning – 100% digital warehouses – AI driven process automation
• Cost & Margin Pressures: 5 measures to guarantee cost-effectiveness for the next 5 years
• Supply Chain Capability Center: 3 models to organize your supply chain organization  with their advantages and disadvantages

Take advantage of our extensive experience in all regions of the world for end-to-end supply chain strategies, manufacturing footprint optimization, distribution network design and location strategies/selection of sites. With teams in Europe in Frankfurt, Nijmegen and The Hague; in the US in Atlanta, San Francisco and LA; and in Asia in Singapore, Shanghai, Taipei and Delhi we support companies like Abbvie, Amgen, Bio-Rad, Ferring, J&J, Novartis, Takeda, Lilly and others.

Presented by

• Johan Beukema, Managing Partner, Manufacturing Footprint & Location Strategies, contact Johan at Johan.Beukema@bciglobal.com
• Frank Hofstee, Partner Pharma & Medtech, contact Frank at Frank.Hofstee@bciglobal.com